BioWorld-International-2004-08-04
Zeltia Subsidiary Neuropharma Brings In EUR16M For Alzheimer's
Zeltia Subsidiary Neuropharma Brings In EUR16M For Alzheimer's
Neuropharma SA, a subsidiary of Zeltia Group, raised 16 million in its first external funding round to progress several preclinical programs in Alzheimer's disease. (BioWorld International)

